CoChat

Respiratory infections in patients with cystic fibrosis undergoing lung transplantation

Lobo, Leonard J, Noone, Peadar G · 2014 · The Lancet Respiratory Medicine

The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.

Abstract

Cystic fibrosis is an inherited disease characterised by chronic respiratory infections associated with bronchiectasis. Lung transplantation has helped to extend the lives of patients with cystic fibrosis who have advanced lung disease. However, persistent, recurrent, and newly acquired infections can be problematic. Classic cystic fibrosis-associated organisms, such as Staphylococcus aureus and Pseudomonas aeruginosa, are generally manageable post-transplantation, and are associated with favourable outcomes. Burkholderia cenocepacia poses particular challenges, although other Burkholderia species are less problematic. Despite concerns about non-tuberculous mycobacteria, especially Mycobacterium abscessus, post-transplantation survival has not been definitively shown to be less than average in patients with these infections. Fungal species can be prevalent before and after transplantation and are associated with high morbidity, so should be treated aggressively. Appropriate viral screening and antiviral prophylaxis are necessary to prevent infection with and reactivation of Epstein-Barr virus and cytomegalovirus and their associated complications. Awareness of drug pharmacokinetics and interactions in cystic fibrosis is crucial to prevent toxic effects and subtherapeutic or supratherapeutic drug dosing. With the large range of potential infectious organisms in patients with cystic fibrosis, infection control in hospital and outpatient settings is important. Despite its complexity, lung transplantation in the cystic fibrosis population is safe, with good outcomes if the clinician is aware of all the potential pathogens and remains vigilant by means of surveillance and proactive treatment.

Overview

Integrity signals

Registry

Crossref · 10.1016/s2213-2600(13)70162-0

Cites

82 of 82 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 82 references

Cited by

See all 64

Metadata

Authors
Lobo, L. J., & Noone, P. G.
Affiliations
  • Duke University (US)
  • University of North Carolina at Chapel Hill (US)
Corresponding author
Noone, Peadar G
Venue
The Lancet Respiratory Medicine
Publisher
Elsevier BV
Published
2014-01
Volume
2
Issue
1
Pages
73-82
ISSN
2213-2600 (ISSN-L)
OpenAlex
W1997740307
Cited by
64
References
82
Citations by year
2026: 1 · 2025: 2 · 2024: 4 · 2023: 3 · 2022: 2 · 2021: 17 · 2020: 6 · 2019: 4 · 2018: 7 · 2017: 4 · 2016: 7 · 2015: 5 · 2014: 1
FWCI
0.77
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet Respiratory Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
  • Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
Keywords
cystic fibrosis, lung transplantation, respiratory infections, Burkholderia cenocepacia, Burkholderia, nontuberculous mycobacteria, Mycobacterium abscessus, Staphylococcus aureus, Pseudomonas aeruginosa, Epstein-Barr virus, cytomegalovirus, antiviral prophylaxis, fungal infection, pharmacokinetics, drug interactions, infection control, post-transplant survival
MeSH terms
Cystic Fibrosis, Humans, Lung, Mycobacterium Infections, Nontuberculous, Mycoses, Postoperative Complications, Respiratory Tract Infections, Staphylococcal Infections, Virus Diseases, Lung Transplantation, Gram-Negative Bacterial Infections, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Respiratory infections in patients with cystic fibrosis undergoing lung transplantation. https://app.cochat.ai/papers/10.1016/s2213-2600(13)70162-0
The paper
Lobo, L. J., & Noone, P. G. (2014). Respiratory infections in patients with cystic fibrosis undergoing lung transplantation. The Lancet Respiratory Medicine. https://doi.org/10.1016/s2213-2600(13)70162-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.